title: Daily exercise and bone marrow-derived CD34+/133+ cells after myocardial infarction treated by bare metal stent implantation.
abstract: BACKGROUND
  The aims of the present study were to explore the mobilization of bone marrow-derived CD34(+)/133(+) cells in patients with acute myocardial infarction (AMI) and bare metal stent implantation who participated in daily exercise training, and associations with exercise capacity and restenosis.
  
  
  RESULTS
  Participants comprised 23 Japanese men with AMI (Killip 1) who had been treated with a bare metal stent. All patients were advised to walk for 30-60 min/day, at least 4 times per week starting at 11 days after AMI, and were instructed to record the amount of time spent walking each day. At 10 days and then at 3 months after onset of AMI, symptom-limited cardiopulmonary exercise tests were performed and the number of CD34(+)/133(+) cells in the peripheral blood were measured by fluorescence-activated cell sorter analysis. At 3 months after AMI, the number of CD34(+)/133(+) cells and oxygen consumption at anaerobic threshold were higher in the high exercise group (ie, exercise duration >4 h/week) than the low exercise group (ie, exercise duration <2 h/week). At 3 months after AMI, the number of CD34(+)/133(+) cells significantly correlated with oxygen consumption at the anaerobic threshold (p=0.002).
  
  
  CONCLUSIONS
  Moderate daily exercise of >4 h/week increases exercise capacity and the number of circulating CD34(+)/133(+) cells at 3 months after AMI.
authors.affiliation: First Department of Integrated Medicine, Omiya Medical Center, Jichi Medical University, Saitama, Japan.
authors.forename: Nahoko
authors.initials: N
authors.lastname: Ikeda
authors.forename: Takanori
authors.initials: T
authors.lastname: Yasu
authors.forename: Norifumi
authors.initials: N
authors.lastname: Kubo
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Nakamura
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Sugawara
authors.forename: Shin-Ichiro
authors.initials: S
authors.lastname: Ueda
authors.forename: San-E
authors.initials: SE
authors.lastname: Ishikawa
authors.forename: Muneyasu
authors.initials: M
authors.lastname: Saito
authors.forename: Masanobu
authors.initials: M
authors.lastname: Kawakami
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Momomura
mesh_terms: D000368:Aged; D015308:Anaerobic Threshold; D015906:Angioplasty, Balloon, Coronary; D018952:Antigens, CD34 / Q000378:metabolism; D023903:Coronary Restenosis / Q000473:pathology / Q000517:prevention & control; D042783:Endothelial Cells / Q000166:cytology; D015444:Exercise; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D008297:Male; D008670:Metals; D008875:Middle Aged; D009203:Myocardial Infarction / Q000473:pathology* / Q000628:therapy*; D010809:Physical Fitness; D011446:Prospective Studies; D015607:Stents
chemical_list: D018952:Antigens, CD34; D008670:Metals